Welcome to our company !

Call us now

08071794342

Velasof Tablets

Velasof Tablets

Product Details:

  • Features Fixed dose combination therapy, Antiviral medication
  • Shelf Life 36 months
  • Function Chronic HCV infection treatment
  • Frequency Once daily (as prescribed)
  • Usage Type Prescription Only
  • Storage Instructions Store below 30C, away from moisture
  • Equipment Type Pharmaceutical Tablet
  • Click to View more
X

Velasof Tablets Price And Quantity

  • 100 Bottle

Velasof Tablets Product Specifications

  • Hepatitis C Virus (HCV) Treatment
  • New, Sealed Pack
  • Once daily (as prescribed)
  • No
  • Fixed dose combination therapy, Antiviral medication
  • Pharmaceutical formulation
  • 36 months
  • Chronic HCV infection treatment
  • No
  • Oral Administration
  • Store below 30C, away from moisture
  • Pharmaceutical Tablet
  • Prescription Only
  • Yes
  • Velasof
  • Tablet
  • Prescription Only
  • Oral
  • 28 Tablets per bottle
  • Antiviral agents
  • Sofosbuvir 400 mg + Velpatasvir 100 mg

Product Description

Velasof tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velasof tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

If you have a known allergy or hypersensitivity to Velasof tablet or any of the components of the medication, you should not take it. The safety and efficacy of sofosbuvir and velpatasvir combination therapy have not been established in children under 18. Its use in the pediatric population is currently limited. It is recommended to use alternative treatment options or adjust the dosage in these cases. 



Advanced Antiviral Therapy

Velasof Tablets utilize a fixed-dose combination of Sofosbuvir and Velpatasvir, offering a comprehensive approach for treating chronic HCV infection. These agents work synergistically to inhibit crucial enzymes in the hepatitis C virus, significantly boosting treatment success rates across various HCV genotypes.


Simple once-daily Dosing

With Velasof, patients benefit from an easy-to-follow once-daily oral regimen. The user-friendly dosing schedule helps maintain adherence to therapy, playing a critical role in achieving and sustaining viral clearance. Each bottle contains a 28-day supply, optimizing convenience and continuity of care.

FAQ's of Velasof Tablets:


Q: How should Velasof Tablets be taken for hepatitis C treatment?

A: Velasof Tablets are taken orally, usually once daily, exactly as prescribed by your healthcare provider. It is vital to swallow the tablet whole with water, at the same time each day, and to complete the full course as instructed.

Q: What are the main benefits of the fixed-dose combination in Velasof?

A: Velasof combines Sofosbuvir and Velpatasvir in a single tablet, simplifying treatment, enhancing patient adherence, and offering broad antiviral coverage against multiple HCV genotypes, which increases the chance of virus elimination.

Q: When is the right time to start Velasof therapy?

A: Your healthcare provider will assess your HCV infection stage and medical history to determine the optimal time to initiate Velasof treatment. Early intervention can help prevent complications and improve long-term outcomes.

Q: Where should Velasof be stored for maximum efficacy?

A: Store Velasof Tablets in their original sealed bottle below 30C, away from direct sunlight and moisture, to maintain stability and potency throughout their 36-month shelf life.

Q: What is the process for obtaining Velasof Tablets?

A: Velasof is a prescription-only medication. You need a diagnosis of HCV and a prescription from a licensed physician. The product is available through authorized distributors, exporters, suppliers, and traders in India.

Q: Is Velasof suitable for all Hepatitis C genotypes?

A: Yes, the combination of Sofosbuvir and Velpatasvir in Velasof is effective against a wide range of HCV genotypes, making it suitable for most chronic HCV infections. Your doctor will confirm its appropriateness for your specific genotype.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Hepatitis Medicine' category



Back to top